Mark Dransfield, Nathaniel Marchetti, Ravi Kalhan, Daniel Reyner, Amy L Dixon, Tara Rheault, Kathleen Ann Rickard and Antonio Anzueto
Antonio Anzueto, Igor Z Barjaktarevic, Thomas M Siler, Tara Rheault, Thomas Bengtsson, Kathleen Rickard and Frank Sciurba
James F Donohue, Tara Rheault, Margot MacDonald-Berko, Thomas Bengtsson, Kathleen Rickard
Gary T Ferguson, Edward M Kerwin, Tara Rheault, Thomas Bengtsson, Kathleen Rickard
Mark Turner, Nurlan Dauletbaev, Larry Lands and John W. Hanrahan
Henrik Watz, Kathleen Rickard, Tara Rheault, Thomas Bengtsson, Dave Singh
Dave Singh, Fernando J. Martinez, Henrik Watz, Thomas Bengtsson, Brian T. Maurer
Tara Rheault and Margot Macdonald-Berko
Leif Bjermer, Katharine Abbott-Banner, Kenneth Newman
David Singh, Katharine Abbot-Banner, Thomas Bergtsson, Kenneth Newman
Lui G Franciosi, PhD, Prof. Zuzana Diamant, MD, Katharine H Banner, PhD, Rob Zuiker, MD, Nicoletta Morelli, MD, Ingrid M C Kamerling, PhD, Marieke L de Kam, MSc, Prof. Jacobus Burggraaf, MD, Prof. Adam F Cohen, MD, Prof. Mario Cazzola, et al.
Katharine H. Abbott-Banner and Clive P. Page
Franciosi L, Diamant Z, Morelli N, de Kam M, Cohen A, Walker M, Page CP.
Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.